24
▲ 50% vs 2024
publications on virtual cell models in 2025
20182025
What the chart shows
Virtual cell models aim to predict how cells respond to drugs or genetic changes without a laboratory experiment. RAISE Health counted 24 publications on them in 2025, up from 16 in 2024 and four times the 6 of 2018.
The numbers are small and uneven: 2021 (14) had more than 2022 (10). Notable 2025 releases named by the AI Index include Evo 2 from the Arc Institute, STATE and DeepMind’s AlphaGenome, and it notes that these systems still need experimental validation.
Key numbers
| Measure | Value |
|---|---|
| 2025 | 24 |
| 2024 | 16 |
| 2023 | 14 |
| 2021 | 14 |
| 2018 | 6 |
How to read it
- PubMed publications identified by RAISE Health as being about virtual cell models.
- With so few papers a year, single-year changes say little.
Source: RAISE Health, 2026, via the AI Index Report 2026 (Stanford HAI), figure 6.1.11: Number of publications on virtual cell models, 2018–25. Chart and text by AI Adoption.
Numbers checked against the published data on 20 October 2026.
Download the data (CSV) · Cite this chart
Numbers checked against the published data on 20 October 2026.
Download the data (CSV) · Cite this chart
Discussion